Table 1. Main STAT3 modulators and their effects in immune cells.
Cell type | pSTAT3 modulators | Effects |
---|---|---|
CD4+ T cell |
IL-27 |
↑ proliferation |
Th17 |
IL-6, IL-21, IL-23 |
↑ RORγt and RORα expression and ↑ cell differentiation ↑ IL-21, IL-23R and IL-17 |
IL-6 (in combination with TGF-β) |
↑ CD39 and CD73 expression and ↑ adenosine production |
|
Treg |
IL-2 |
↑ Foxp3 expression (associated with pSTAT5) and ↑ inhibitory functions |
IL-6, IL-27 |
↓ Foxp3 expression (with an inhibition of pSTAT5 binding) and inhibition of differentiation |
|
|
↑ IL-6, TGF-β (with Foxp3 cooperation) |
|
Macrophage |
IL-6 |
Inhibition of differentiation |
|
Inhibition of Ag presentation to CTL, ↑ IL-23 and ↓ IL-12 production Inhibition of LPS-mediated cytokine production (e.g., RANTES and IL-12) |
|
Tumor cell supernatants |
↑ IL-10, βFGF and VEGF-A production and ↑ angiogenesis |
|
DC |
|
Inhibition of Ag presentation to CTL and ↓ TLR induced IL-12 and TNF-α production |
Tumor cell supernatants, IL-6 and exosomes |
↓ differentiation (with an IL-6 amplification loop) |
|
MDSC | exosomes |
↑ immunosuppressive functions (with an IL-6 amplification loop) |
Tumor cell supernatant |
↑ production of VEGF and βFGF and ↑ angiogenesis |
|
↑ expression of NOX2, ↑ production of ROS and ↑ immunosuppressive functions |